Yusuf Samet Atlıhan

Dr. Yusuf Samet Atlıhan

Department of Ophthalmology, Akdeniz University Hospital, Antalya, Turkey (Türkiye)
orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 September 2025 in International Ophthalmology
Verified
Journal Article
Closed access
PDF file
Yusuf Samet AtlıhanYusuf Samet Atlıhan
Yusuf Samet Atlıhan
ÇPÇisil Erkan Pota
Çisil Erkan Pota
AYAslı Çetinkaya Yaprak
Aslı Çetinkaya Yaprak

1 March 2025 in Diagnostics
Verified
Journal Article
Open access
PDF file
ÖKözlem Karataş
özlem Karataş
ÇPÇisil Erkan Pota
Çisil Erkan Pota
BABulent Akyuz
Bulent Akyuz
Yusuf Samet AtlıhanYusuf Samet Atlıhan
Yusuf Samet Atlıhan
KPKaan Pota
Kaan Pota
STSerpil Tuna
Serpil Tuna
Objectives: The aim of this study was to investigate retinal and choroidal microvascular changes in patients with axial spondyloarthritis (axSpA) treated with long-term anti-TNF therapy and NSAIDs and in healthy control subjects using optical coherence tomography angiography (SS-OCT-A). Methods: A total of 162 eyes from 81 participants were included: 52 eyes from 26 axSpA patients treated with anti-TNF therapy (≥5 years), 44 eyes from 22 axSpA patients treated with NSAIDs, and 66 eyes from 33 healthy control subjects. SS-OCT-A imaging was used to assess retinal thickness, ganglion cell layer thickness, retinal nerve fiber layer thickness, and the vessel densities of the superficial capillary plexus (SCP), deep capillary plexus (DCP), and choriocapillaris (CC). Disease activity was assessed with ASDAS-CRP. Results: Both axSpA subgroups showed a significant expansion of the foveal avascular zone and reduced SCP and DCP densities compared to the controls. The CC vessel density was higher in axSpA patients than in healthy subjects. The anti-TNF group had a lower CC vascular density than the NSAIDs group. The disease duration correlated with a decreased central DCP density and increased paracentral SCP and CC densities. Conclusions: SS-OCT-A revealed subclinical retinal and choroidal changes in axSpA patients, highlighting the impact of chronic inflammation on the retinal vasculature. While anti-TNF therapy effectively controls systemic inflammation, it cannot completely prevent microvascular changes. Further studies are needed to assess the clinical relevance of these results.

26 September 2025 in Cell Biology International
Verified
Journal Article
Closed access
Yusuf Samet AtlıhanYusuf Samet Atlıhan
Yusuf Samet Atlıhan
AÜAleyna Öztüzün Ün
Aleyna Öztüzün Ün
HBHazal Tuzcu Balaban
Hazal Tuzcu Balaban
EKEsma Kırımlıoğlu
Esma Kırımlıoğlu
CBCumhur İbrahim Başsorgun
Cumhur İbrahim Başsorgun
Mutay Aydın AslanMutay Aydın Aslan
Mutay Aydın Aslan

8 April 2026 in European Journal of Ophthalmology
Verified
Journal Article
Closed access
OÖOlgar Öcal
Olgar Öcal
Yusuf Samet AtlıhanYusuf Samet Atlıhan
Yusuf Samet Atlıhan
OÖOzan Özgül
Ozan Özgül
İBİbrahim Başol
İbrahim Başol
HIH Deniz Ilhan
H Deniz Ilhan
Purpose: This study aimed to investigate the relationship between extraocular muscle (EOM) insertion involvement and clinical activity in patients with thyroid eye disease. Methods: This cross-sectional retrospective study included 292 eyes from 292 patients who underwent comprehensive ophthalmologic examination. Patients were divided into two groups based on the presence (Group 1) or absence (Group 2) of medial rectus muscle insertion involvement. Involvement was defined as hypertrophy and/or vascularization of the muscle insertion observed on slit-lamp examination. Ophthalmologic assessment included best-corrected visual acuity (BCVA, LogMAR), refractive error, intraocular pressure (IOP), slit-lamp examination of the anterior segment, dilated fundus examination, and Hertel exophthalmometry for both eyes. Additionally, magnetic resonance imaging (MRI) findings were evaluated for all patients. Results: Our study included 71 patients in group 1 and 221 patients in group 2. The mean follow-up period was 4 ± 2 (2–8) years. Clinical activity score (CAS) and HE values were statistically significantly higher in the first group ( p < 0.001). MRI analysis revealed significantly greater EOM enhancement in Group 1 ( p < 0.05). Among patients with insertional involvement, 45 had CAS ≥ 4 and 26 had CAS ≤ 3. Statistically significant regression was observed in the CAS of patients with CAS ≤ 3, with insertional involvement and who were started on corticosteroid treatment. Conclusion: The CAS was significantly higher in patients with medial rectus insertion involvement on biomicroscopic examination ( p < 0.001), suggesting that this finding may serve as an additional indicator of disease activity.

10 April 2026 in European Journal of Ophthalmology
Verified
Journal Article
Closed access
Yusuf Samet AtlıhanYusuf Samet Atlıhan
Yusuf Samet Atlıhan
APAli Pota
Ali Pota
DSDoğa Akay Salihoğlu
Doğa Akay Salihoğlu
GBGul Alkan Bulbul
Gul Alkan Bulbul
Purpose: Pregnancy induces hormonal changes that can affect various organ systems, including ocular structures. This study aimed to evaluate changes in anterior segment (AS) parameters, higher-order aberrations (HOAs), and aqueous humour (AH) optical density (OD) in pregnant women compared to healthy controls. Methods: This prospective case–control study included 45 healthy pregnant women and 47 age-matched non-pregnant controls. Comprehensive ophthalmological examinations were performed, including best-corrected visual acuity (BCVA), intraocular pressure, spherical equivalent, axial length, central corneal thickness, corneal volume, corneal curvature (K1, K2, Km), AS parameters, and endothelial cell metrics. HOAs (coma, trefoil, spherical aberration) and AH OD were also assessed. Ocular surface evaluations included the OSDI questionnaire, Schirmer test and tear break-up time. Pregnant participants were assessed in each trimester and three months postpartum, with comparisons conducted both cross-sectionally against healthy controls and longitudinally within the pregnancy cohort across trimesters and postpartum. Results: RMS-HOA was higher in the third trimester (0.41 ± 0.19 µm, p = 0.003) and postpartum (0.39 ± 0.31 µm, p = 0.041). RMS-total increased in the second (1.64 ± 0.21 µm, p = 0.031) and third trimesters (1.63 ± 0.46 µm, p = 0.022). Coma was higher in the second (1.64 ± 0.34 µm, p = 0.045) and third trimesters (1.61 ± 0.29 µm, p = 0.040), and trefoil increased in the third trimester (1.50 ± 0.35 µm, p = 0.027). AH OD was higher than in controls at every time point, measuring 4.74 ± 0.41% in the first trimester ( p = 0.007), 4.81 ± 0.50% in the second ( p = 0.001), 4.96 ± 0.42% in the third ( p = 0.001), and 4.79 ± 0.46% postpartum ( p = 0.020). BCVA was unchanged. Conclusion: In pregnancy, small increases in HOAs and AH OD are typically subclinical and reflect physiological change rather than pathology.

18 December 2025 in Archivos de la Sociedad Española de Oftalmología
Verified
Journal Article
Closed access
Yusuf Samet AtlıhanYusuf Samet Atlıhan
Yusuf Samet Atlıhan